Skip to main content

Table 1 Prevalence and incidence AHR Colombia 2010–2014

From: 7th drug hypersensitivity meeting: part one

 

2010 % (n)

2011 % (n)

2012 % (n)

2013 % (n)

2014 % (n)

Prevalence AHR Colombia

Cases per million

 1–5 años

0.4 (1)

5.1 (17)

2.4 (9)

5.2 (17)

3.8 (13)

 6–9 años

5.4 (15)

6.9 (23)

4 (15)

5.2 (17)

3.2 (11)

 10–14 años

8 (22)

6.3 (21)

9.2 (35)

10.8 (35)

12.1 (42)

 15–18 años

8.3 (23)

6.9 (23)

7.4 (28)

7.7 (25)

10.8 (37)

 19–26 años

14.9 (41)

13.9 (46)

19.8 (75)

18.8 (61)

16.8 (58)

 27–44 años

34.8 (96)

32 (106)

29.8 (113)

26.2 (85)

27.7 (96)

 45–59 años

19.2 (53)

19 (63)

16.4 (62)

16.6 (54)

14.5 (50)

 >60 años

9.1 (25)

9.7 (32)

11.1 (42)

9.5 (31)

11.3 (39)

 Total

100 (276)

100 (331)

100 (379)

100 (325)

100 (346)

Incidence AHR Colombia

Cases per million

 1–5 años

0 (0)

0 (0)

0 (0)

2.5 (1)

8.2 (4)

 6–9 años

5.4 (3)

0 (0)

2.4 (1)

5 (2)

10.2 (5)

 10–14 años

8 (4)

9.3 (5)

9.5 (4)

2.5 (1)

10.2 (5)

 15–18 años

8.3 (2)

7.4 (4)

7.1 (3)

10 (4)

18.4 (9)

 19–26 años

14.9 (4)

20.4 (11)

21.4 (9)

22.5 (9)

20.4 (10)

 27–44 años

34.8 (10)

35.2 (19)

26.2 (11)

25 (10)

16.3 (8)

 45–59 años

19.2 (8)

18.5 (10)

23.8 (10)

22.5 (9)

8.2 (4)

 >60 años

9.1 (7)

9.3 (5)

9.5 (4)

10 (4)

8.2 (4)

 Total

100 (38)

100 (54)

100 (42)

100 (40)

100 (49)